Fig. 9From: Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-cateninImmmunofluorescence was used to show the β-catenin expression after Hs578T cells and BT20 cells were transfected with Nek2B siRNA (a) and MDA-MB-231 cells and 468 cells were transfected with Nek2B plasmid (b)Back to article page